Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study
Background Caffeine citrate (CC)-induced excessive energy expenditure, diuresis, natriuresis, and other CC-associated potential side effects (CC-APSEs) result in lower daily weight gain (WG) in premature neonates. This study aimed to assess higher CC-doses’ effect on the mean daily-WG (MD-WG) and CC...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-04-01
|
Series: | Dose-Response |
Online Access: | https://doi.org/10.1177/15593258241247185 |
_version_ | 1827284560452255744 |
---|---|
author | Ijaz Hussain Manoj Kumar Amin Ali Fizzah Naz Wasif Ahmed Khan Muhammad Sohail Salat Shahzad Rauf Gul Ambreen Kashif Hussain |
author_facet | Ijaz Hussain Manoj Kumar Amin Ali Fizzah Naz Wasif Ahmed Khan Muhammad Sohail Salat Shahzad Rauf Gul Ambreen Kashif Hussain |
author_sort | Ijaz Hussain |
collection | DOAJ |
description | Background Caffeine citrate (CC)-induced excessive energy expenditure, diuresis, natriuresis, and other CC-associated potential side effects (CC-APSEs) result in lower daily weight gain (WG) in premature neonates. This study aimed to assess higher CC-doses’ effect on the mean daily-WG (MD-WG) and CC-APSE development, considering 5 mg/kg/day as the standard regimen. Method This retrospective cohort study included neonates of ≤36 weeks gestational age and received CC-therapy. The same participants were followed for data analysis in two postnatal phases: 15–28 and 29–42 days of life (DOL). Based on daily CC-dose, formed group-I=(5 mg/kg/day), group-II=(>5–7 mg/kg/day), and group-III=(>7 mg/kg/day). Data was analyzed separately for group-II and group-III using group-I as the standard. Results The study included 284 neonates. During phase-I, the MD-WG was significantly higher in group-I than group-II (19.9 ± .88 g/kg/d vs 17.5 ± .49, P = .031) and group-III (19.9 ± .88 g/kg/d vs 16.7 ± .71, P < .001). During 29–42 DOL, the MD-WG of group-I was only significantly higher than group-III (21.5 ± .42 g/kg/d vs 18.1 ± .39 g/kg/d, P = .003) and comparable with group-II. During 15–28 DOL, CC-APSEs were significantly higher in group-II and group-III but during 29–42 DOL was significant only in group-III. Conclusion Exposure to higher caffeine doses in this study cohort is associated with lower postnatal WG in preterm neonates than standard daily doses may be due to its catabolic effects and CC-APSEs. |
first_indexed | 2024-04-24T09:58:25Z |
format | Article |
id | doaj.art-27180460c89d47f78269fa0aa01b8d62 |
institution | Directory Open Access Journal |
issn | 1559-3258 |
language | English |
last_indexed | 2024-04-24T09:58:25Z |
publishDate | 2024-04-01 |
publisher | SAGE Publishing |
record_format | Article |
series | Dose-Response |
spelling | doaj.art-27180460c89d47f78269fa0aa01b8d622024-04-14T02:04:39ZengSAGE PublishingDose-Response1559-32582024-04-012210.1177/15593258241247185Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort StudyIjaz HussainManoj KumarAmin AliFizzah NazWasif Ahmed KhanMuhammad Sohail SalatShahzad RaufGul AmbreenKashif HussainBackground Caffeine citrate (CC)-induced excessive energy expenditure, diuresis, natriuresis, and other CC-associated potential side effects (CC-APSEs) result in lower daily weight gain (WG) in premature neonates. This study aimed to assess higher CC-doses’ effect on the mean daily-WG (MD-WG) and CC-APSE development, considering 5 mg/kg/day as the standard regimen. Method This retrospective cohort study included neonates of ≤36 weeks gestational age and received CC-therapy. The same participants were followed for data analysis in two postnatal phases: 15–28 and 29–42 days of life (DOL). Based on daily CC-dose, formed group-I=(5 mg/kg/day), group-II=(>5–7 mg/kg/day), and group-III=(>7 mg/kg/day). Data was analyzed separately for group-II and group-III using group-I as the standard. Results The study included 284 neonates. During phase-I, the MD-WG was significantly higher in group-I than group-II (19.9 ± .88 g/kg/d vs 17.5 ± .49, P = .031) and group-III (19.9 ± .88 g/kg/d vs 16.7 ± .71, P < .001). During 29–42 DOL, the MD-WG of group-I was only significantly higher than group-III (21.5 ± .42 g/kg/d vs 18.1 ± .39 g/kg/d, P = .003) and comparable with group-II. During 15–28 DOL, CC-APSEs were significantly higher in group-II and group-III but during 29–42 DOL was significant only in group-III. Conclusion Exposure to higher caffeine doses in this study cohort is associated with lower postnatal WG in preterm neonates than standard daily doses may be due to its catabolic effects and CC-APSEs.https://doi.org/10.1177/15593258241247185 |
spellingShingle | Ijaz Hussain Manoj Kumar Amin Ali Fizzah Naz Wasif Ahmed Khan Muhammad Sohail Salat Shahzad Rauf Gul Ambreen Kashif Hussain Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study Dose-Response |
title | Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study |
title_full | Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study |
title_fullStr | Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study |
title_full_unstemmed | Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study |
title_short | Dose–Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates—A Retrospective Cohort Study |
title_sort | dose response study of caffeine on postnatal weight gain in premature neonates a retrospective cohort study |
url | https://doi.org/10.1177/15593258241247185 |
work_keys_str_mv | AT ijazhussain doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy AT manojkumar doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy AT aminali doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy AT fizzahnaz doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy AT wasifahmedkhan doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy AT muhammadsohailsalat doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy AT shahzadrauf doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy AT gulambreen doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy AT kashifhussain doseresponsestudyofcaffeineonpostnatalweightgaininprematureneonatesaretrospectivecohortstudy |